Description
Broad spectrum of activity against Gram+ve, Gram-ve& typical pathogens. Rapidly penetrates phagocytic cells, with the release at local sites of infection. Maintains sustained pulmonary tissue concentraions higher than MICs for major Respiratory Pathogens. 3-day regimen of azithromycin is as effective as a 10-day regiment of co-amoxiclav in the treatment of acute lower respiratory tract infections.
Excellent patient compliance with 3-days once daily dosing.
Genotourinary Tract Infections
Community Acquired Pneumonia
Infected Dermatitis/Tonsillitis/Sinusitis
Acute Bacterial Exacerbations of Chronic Bronchitis
